Search

  • HOME
  • Search
Correspondence
Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
Haolong Li, Song Liu, Xu Wang, Li Wang, Tengda Xu, Yongzhe Li
Clin Mol Hepatol. 2025;31(2):e194-e196.   Published online February 24, 2025
View: 797   Download: 32
Original Article
2130
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
Haolong Li, Song Liu, Xu Wang, Xinxin Feng, Siyu Wang, Yanli Zhang, Fengchun Zhang, Li Wang, Tengda Xu, Yongzhe Li
Clin Mol Hepatol. 2025;31(2):474-488.   Published online December 30, 2024
View: 1662   Download: 154  Web of Science: 3  Crossref: 3
Review
2093
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
Atsumasa Komori, Yuki Kugiyama
Clin Mol Hepatol. 2025;31(1):90-104.   Published online November 11, 2024
View: 2088   Download: 225  Web of Science: 1  Crossref: 1
Reply to Correspondence
Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances”
Byoung Kuk Jang
Clin Mol Hepatol. 2024;30(2):297-298.   Published online April 1, 2024
View: 2579   Download: 46
Original Article
1877
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang, Xiu-Ping Liu, Jian Wu
Clin Mol Hepatol. 2024;30(2):206-224.   Published online January 8, 2024
View: 6111   Download: 264  Web of Science: 5  Crossref: 5
Editorial
JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Clin Mol Hepatol. 2024;30(2):166-167.   Published online March 8, 2024
View: 3228   Download: 81  Web of Science: 1  Crossref: 1
Letter to the Editor
Forms of cholangitis to be considered after SARS-CoV-2 infection
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clin Mol Hepatol. 2022;28(4):929-930.   Published online September 8, 2022
View: 3518   Download: 70  Web of Science: 2  Crossref: 3
1702
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Clin Mol Hepatol. 2022;28(4):926-928.   Published online September 5, 2022
View: 3477   Download: 80  Web of Science: 2  Crossref: 3
Clinical and serological prognostic markers in primary biliary cholangitis
Markus Wilhelmi
Clin Mol Hepatol. 2021;27(2):360-361.   Published online March 23, 2021
View: 4759   Download: 120
Review
1398
Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea
Sook-Hyang Jeong
Clin Mol Hepatol. 2018;24(1):10-19.   Published online January 5, 2018
View: 12571   Download: 298  Web of Science: 19  Crossref: 18
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2732
TOTAL : 2790423
Close layer